Patienter med behov for kontrol af blod - glukoseniveauet bør under behandling med ORENCIA tilrådes anden metode, der ikke reagerer på maltose, fx en metode baseret på glukosedehydrogenase nikotinadenindinucleotid (GDH- NAD), glukoseoxidase eller glukosehexokinase.
When receiving ORENCIA, patients that require blood glucose monitoring should be advised to consider methods that do not react with maltose, such as those based on glucose dehydrogenase nicotine adenine dinucleotide (GDH-NAD), glucose oxidase, or glucose hexokinase test methods.